Perma-Fix to Present at the SeeThruEquity Microcap Investor Conference in NYC
ATLANTA, GA -- (Marketwired) -- 11/07/14 -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) today announced that Dr. Louis Centofanti, CEO of Perma-Fix will present at the SeeThruEquity Microcap Investor Conference on Wednesday, November 12th at 9:00 A.M. EST at the Convene Midtown East in New York City located at 730 Third Avenue.
The webcast and a copy of the Company's slide presentation will be available on the investor relations section of the Company's website at http://www.perma-fix.com.
Members of the investment community interested in meeting with the Company's management during the conference can contact a representative at SeeThruEquity and can register to attend for the conference at the following link: http://www.meetmax.com/sched/event_28843/investor_reg_new.html?event_id=28843&cmd=register.
About SeeThruEquity
SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The Company's research is not paid for and is unbiased as it does not conduct any investment banking or commission based business. SeeThruEquity's research is contributed to by Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks and distributed to its opt-in investors along with Thomson Estimates, the leading estimates platform on Wall Street.
SeeThruEquity Conferences are held approximately every quarter throughout the year and host industry professionals and investors who are looking for new ideas, opportunities, and corporate relationships. For more information, visit www.seethruequity.com.
About Perma-Fix Environmental Services
Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the Department of Energy ("DOE"), the Department of Defense ("DOD"), and the commercial nuclear industry. The Company's nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The Company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOD, and commercial facilities, nationwide. Please visit us on the World Wide Web at http://www.perma-fix.com.
Perma-Fix Medical, a subsidiary of Perma-Fix Environmental Services, Inc., was formed to develop, obtain the U.S. Food and Drug Adminstration ("FDA") and other regulatory approval and commercialize a new process to produce Technetium-99 (Tc-99m), the most widely used medical isotope in the world. The new process is expected to address global supply chain concerns related to Tc-99m as it is less expensive, does not require the use of government-subsidized, weapons-grade materials and can be easily deployed around the world using standard research and commercial reactors, thereby eliminating the need for special purpose reactors. Additional information is available at http://www.medical-isotope.com.
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020, ext. 304
Source: Perma-Fix Environmental Services, Inc.
Released November 7, 2014